SK Biopharmaceuticals prices at top of range for S Korea's biggest IPO in 3 yrs

Drugmaker SK Biopharmaceuticals Co Ltd priced its initial public offering on Friday at the top of its indicative range, aiming to raise 959 billion won ($794 million) in South Korea’s biggest IPO in three years.